Consolidated Portfolio Review Corp’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
+2,818
| New | +$246K | 0.03% | 390 |
|
|
2025
Q1 | – | Sell |
-2,824
| Closed | -$220K | – | 383 |
|
|
2024
Q4 | $220K | Buy |
+2,824
| New | +$220K | 0.03% | 341 |
|
|
2024
Q3 | – | Sell |
-2,824
| Closed | -$320K | – | 315 |
|
|
2024
Q2 | $320K | Buy |
2,824
+11
| +0.4% | +$1.25K | 0.07% | 228 |
|
|
2024
Q1 | $390K | Buy |
2,813
+205
| +8% | +$28.4K | 0.1% | 180 |
|
|
2023
Q4 | $324K | Sell |
2,608
-29
| -1% | -$3.6K | 0.07% | 222 |
|
|
2023
Q3 | $246K | Buy |
2,637
+29
| +1% | +$2.71K | 0.06% | 269 |
|
|
2023
Q2 | $335K | Hold |
2,608
| – | – | 0.08% | 216 |
|
|
2023
Q1 | $303K | Buy |
+2,608
| New | +$303K | 0.08% | 208 |
|